ANITA PALANDRI: Open Payments
NPI 1851840870 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,021 in 91 payments from 38 companies in 2025. Trend: 2023 $5,534 · 2024 $4,981 · 2025 $2,021
Food & beverage: $2,021
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $223 |
| ABBVIE INC. | 7 | $156 |
| Merck Sharp & Dohme LLC | 6 | $155 |
| Daiichi Sankyo Inc. | 6 | $142 |
| Janssen Biotech, Inc. | 7 | $132 |
| PFIZER INC. | 6 | $126 |
| Celgene Corporation | 4 | $96 |
| Novartis Pharmaceuticals Corporation | 5 | $92 |
| Stemline Therapeutics Inc. | 3 | $76 |
| SpringWorks Therapeutics, Inc. | 2 | $62 |
Products named: KEYTRUDA, Enhertu, IMFINZI, EPKINLY, Orserdu, OPDIVO, VERZENIO, IMBRUVICA.
Industry payments across AZ — which companies pay providers there.
